“Disabled” doctors? They don’t like the term or the implication, and their careers have been anything but limited.
The soaring cost of medical school may be driving graduates away from primary care and into high-paying specialty practices.
All the terrifying world’s a stage, and artists borrow tools of the theater to give models in drills remarkably lifelike wounds and burns.
Few identical twins suffer identical maladies, leading science to probe the significance of epigenetic changes that make paths diverge.
The trend of publishing research on the Web is raising concerns about how medical advances are judged and disseminated.
Out of favor for decades, testosterone replacement therapy is back–and so is the debate about a possible link to prostate cancer.
A cholesterol test for 10-year-olds could show early signs of cardiovascular disease, yet critics warn that this could lead to unnecessary treatment.
Drug availability is getting worse, with essential medicines often impossible to obtain. What will it take to fix the system?
Creating a medicine from scratch takes years and may cost $1 billion. One alternative: recycling failed compounds for new applications.
No Articles Found.